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Background: There is a need for innovative methodologies to identify and prioritize topics
for health technology assessment (HTA). A pilot project to evaluate the methodology for
specialty mapping was undertaken in the area of child and adolescent health. Two case
studies are presented, in the area of sexually transmitted infections and acute pain.
Methods: The methodology comprised sequential stages, based on principles of
systematic review. A “stakeholder model” encouraged wider participation. Key stages
included identifying the topic area and setting the scope; developing a care pathway;
searching for clinical guidelines/guidance, and evaluation literature; synthesis and
mapping of literature to the “nodes” of the care pathway to highlight gaps; prioritizing the
topics with stakeholders; and referring priorities to the appropriate agencies.
Results: A total of thirty guidelines/guidance documents and sixteen evaluation studies
were mapped across the two case studies. In some nodes of the care pathway, more
literature was mapped than others, suggesting important gaps in research and policy
guidance. Sixty-two policy questions were identified and were rated by stakeholders in
prioritization workshops. The highest priorities have been considered by senior
committees for likely commissioning as research or guidelines/guidance.
Conclusions: This is one of the few published examples of innovative methodology to
identify and prioritize topics for HTA. Specialty mapping can make a positive contribution
to the policy agenda, with several research and policy gaps being fed into existing
prioritization channels. Adequate time, resources, and capacity is required particularly in
engaging stakeholders and developing a care pathway. Implementation of specialty
mapping in other topic areas with on-going evaluation is recommended.
Keywords: Health policy; Technology assessment, biomedical; Evidence-based
medicine
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Effective methods for identifying research and guidance pri-
orities are essential to inform health policy and practice. In
the UK policy on the use of health technologies is under-
pinned by the work of several agencies, including the Health
Technology Assessment (HTA) Program and the National
Institute for Health and Clinical Excellence (NICE).
Although there are established systems for identifying
research and guidance priorities in the United Kingdom, it has
become increasingly difficult to engage the wider National
Health Service (NHS) in identifying important topics. For
example, the NHS Research & Development (R&D) HTA
program operates four advisory panels in areas such as di-
agnostics and screening, pharmaceuticals, public health, and
therapeutics. The panels identify and prioritize topics that
are commissioned as primary and secondary research by the
program. This system is regarded to be successful in terms
of capturing the range of technologies relevant to the health
service, and at scoping whether or not evidence for effective-
ness is required. However, there have been few attempts to
evaluate innovative methods of identification and prioritiza-
tion in specific topic areas, particularly capable of engaging
all relevant stakeholders.
Specialty mapping, one such innovation, is a concept
whereby appraisal guidance on the use of specific technolo-
gies in specific conditions; clinical guidelines on the man-
agement of diseases and conditions, and evaluation research
on the effectiveness of health interventions are described and
mapped to identify gaps in the evidence base. The concept
has been discussed over many years, and piloted in a handful
of specialties (3;4;13), but is not widely implemented in the
United Kingdom.
We undertook a pilot project to evaluate the methodol-
ogy for specialty mapping in the area of child and adolescent
health, an area defined as a priority by the Department of
Health (DH) in England (6). The primary aim was to develop
and evaluate the methodology and to disseminate the lessons
learned so that it might be refined and implemented. This was
to be achieved through two pilot specialty maps (i) the pre-
vention and management of sexually transmitted infections
(STIs) in teenagers, and (ii) the recognition, assessment, and
management of acute pain in children and young people (ages
28 days to 19 years). A secondary aim was to identify and
prioritize topics for the NHS R&D HTA program, NICE and,
where relevant, other R&D programs.
In this study, we use the two pilot specialty maps as con-
trasting case studies to describe: (i) How we developed the
methodology, and (ii) How we evaluated the methodology of
specialty mapping, in order that a transparent methodological
framework could be provided and disseminated.
METHODS
Overview
After consideration of various models of participation and the
need to solicit topic suggestions from a broad spectrum of
agencies a “stakeholder model” of participation was chosen.
Relevant stakeholders included policy leads from the DH,
specialists in child health, health service users, and volun-
tary and charitable organizations. Stakeholders were involved
throughout the project.
The outline methodology for the pilot project was spec-
ified in advance (see Figure 1). The key stages were identi-
fying the topic area and setting the scope, developing a care
pathway, searching for evidence and guidance/guidelines,
synthesis and mapping, and prioritizing the topics with stake-
holders. Although we began with aims, objectives, and an
outline methodology, the project was designed to be flexi-
ble and iterative. In keeping with this strategy, we reviewed
and adapted the approach as time went on, a process akin to
action research (18;20).
The pilot project was guided by a steering group with
representatives from the National Coordinating Centre for
Health Technology Assessment (NCCHTA) and the National
Horizon Scanning Centre (NHSC). The steering group con-
vened four times over the 6 months of the pilot.
We worked closely with the Child Health Advisory
Group (CHAG) at the DH in identifying clear priorities for
the pilot project. The CHAG were initially involved in high-
lighting priority areas of child health where guidance was
necessary. They also identified relevant child health prac-
titioners who could help with identifying or designing a
generic care pathway for the topic under study. The map-
ping process itself was to adhere as closely as possible to
established systematic review methodology, with systematic
literature searching, data extraction, critical appraisal, and
synthesis (12;14).
Developing the Care Pathway
A framework was necessary to ensure that, where gaps ex-
isted, they could be identified across all of the relevant pre-
vention and management strategies in a given area. It was
envisaged that, for each pilot topic, a care pathway would
be used as a framework within which to map the literature
(1;7).
We searched for published care pathways that might be
adapted for our purposes. If none were available, a pathway
would be devised and subjected to clinical face validation by
practitioners from the topic area or experts in child health.
Literature Searching
Literature searching was undertaken at the NCCHTA by
an experienced information scientist. Two types of litera-
ture were sought: (i) evaluations of the clinical and cost-
effectiveness of health technologies (e.g., randomized con-
trolled trials and systematic reviews), and (ii) policy literature
published between 1999 and 2004 (clinical guidelines and
guidance on the use of health technologies from technology
appraisals). Several key electronic bibliographic databases
were searched for completed evaluation studies (e.g.,
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Specialty mapping in health technology assessment
1. Prioritization of topic area and
setting the scope
(in collaboration with stakeholders) 
2. Development of a bespoke care
pathway for the topic
(in collaboration with stakeholders)
3. Design and execute search strategy,
using electronic bibliographic
databases, research databases, Internet
sites, and other sources 
4. Synthesis and quality assessment of
included literature. Mapping the
literature to the care pathway
5. Identification of research and
policy gaps. Translation of gaps into
answerable research and policy
questions.
6. Prioritization of research and policy
questions (Using Delphi consensus
seeking methods with stakeholders)
7. Outputs fed into appropriate
programs (clinical guidelines and
guidance for NICE; research priorities
for the HTA Programme)
Figure 1. Outline methodology for specialty mapping.
MEDLINE, The Cochrane Library), and studies in progress
(e.g., National Research Register). Policy literature was
sought from databases of clinical guidelines/guidance (e.g.,
the National Electronic Library for Health “Guidelines
Finder Specialist Library”) as well as Internet sites of rel-
evant organizations (e.g., Scottish Intercollegiate Guidelines
Network [SIGN]).
Inclusion and exclusion criteria were clearly defined at
the outset for each topic area as a result of discussion with
child health experts and the steering group. The results of
the searches were filtered by reviewing individual outputs
for information pertinent to the age group under study.
Synthesis and Mapping
The included literature was read, assimilated, and mapped to
the appropriate nodes of the care pathway. This process was
performed by one researcher and checked by a second. Ad-
ditional areas for intervention along the care pathway were
identified during this assimilation process. Validation of this
process was undertaken by an independent reviewer. The
quality of the guidelines was appraised narratively using
the AGREE appraisal tool (19). Analysis of the populated
care pathway and narrative map (the framework based on the
care pathway) facilitated the identification of gaps in research
evidence and policy literature. The gaps were identified by
(i) analyzing those areas of the care pathway lacking appro-
priate guidelines/guidance or evaluation research, (ii) noting
gaps cited within existing guidelines/guidance or evaluation
research, and (iii) identifying poor-quality and out of date
studies and guidelines/guidance.
Prioritization of Gaps
Prioritization of the identified gaps was undertaken in a “vir-
tual” workshop for each pilot topic using e-mail and the
Delphi consensus technique (11). The CHAG, the DH, and
our steering group identified policy leads, healthcare profes-
sionals, charitable and voluntary groups, and services users
who were invited to join the Delphi workshop. Each gap
identified by the mapping was translated into a specific re-
search or policy question, and a questionnaire containing all
of the questions constructed and piloted before use in the
Delphi exercise.
Two rounds of the Delphi process were undertaken to
reach consensus. In the first round, participants were asked
to independently rank the research or policy questions ac-
cording to their perceived level of importance. The results
were collated for each topic area with the research and policy
questions ranked according to the level of importance identi-
fied in the first round. In the second round, participants were
asked to score their highest priorities with a score of two and
their next most important priorities with a score of one. The
participants were supplied with standard criteria to help them
judge the importance of the topics to policy and practice, as
used by the HTA Program for routine prioritization of topics.
RESULTS
Case Study 1: Prevention and Management
of STIs in Teenagers
Scope. The prevention and management of STIs in
teenagers was chosen in consultation with the DH and the
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CHAG for this pilot project due to the broad nature of the
topic and its relevance to current health policy. The project
focused on the five most prevalent acute STIs in the United
Kingdom (Chlamydia trachomatis, genital warts, Neisseria
gonnorhoea, genital herpes, and infectious syphilis), as well
as HIV/AIDS (21).
Inclusion/exclusion criteria were (i) Age range: young
people ages 11 to 19 years; (ii) Interventions: prevention
and management of STIs, except specific treatment strate-
gies; (iii) Country: UK literature was prioritized, although
international literature was also mapped where relevant.
Care Pathway
Literature searching of electronic sources (e.g., Web sites
of professional organizations) did not yield any published
care pathways that encompassed the prevention and man-
agement of STIs with young people. A bespoke pathway
was, therefore, devised and validated both clinically (through
discussion with health professionals in the area of sexual
health and young people) and operationally (based on exam-
ples of currently used interventions from research databases;
Figure 2). The pathway encompasses a wide range of strate-
gies to promote and maintain good sexual health among
young people at a variety of stages of sexual development. At
the start of the pathway, interventions such as sexual health
education are proposed for those not yet sexually active. For
those who are sexually active, there is a set of strategies
based on whether or not an STI is acquired, and whether
symptomatic or not. Strategies include population and op-
portunistic screening, further investigation, treatment, and
partner notification, where appropriate.
Literature Searching
The search strategy was devised using nationally recognized
terms and validated by the experts responsible for identifying
the generic care pathways. In addition to the sources of liter-
ature mentioned earlier, several topic-specific sources were
searched. These included Web sites of organizations such as
the Health Development Agency (now the Centre for Public
Health Excellence at NICE), and charitable trusts (e.g., the
National AIDS Trust, the Terrence Higgins Trust). Evidence
for the safety and efficacy of new and emerging interven-
tions and technologies currently undergoing evaluation was
sought from emerging technology briefings on STI from in-
ternational horizon scanning collaborators, from news alert
services and NHSC internal databases of technologies in de-
velopment.
Given the limited time available a pragmatic decision
was made not to conduct a specific search for evaluation
evidence in the health promotion literature but to make ex-
tensive use of the two “evidence briefings” of STI prevention
(2004) (9) and HIV prevention (2003) (8) available. Addi-
tional systematic reviews known to the authors of this report
were included in the pilot map (8;9;10;15).
Mapping and Synthesis: Results
A total of fourteen sets of guidelines/guidance, four system-
atic reviews, and twelve primary evaluations were identi-
fied. Figure 2 shows the policy literature and research ev-
idence mapped to the various nodes of the care pathway.
For each node (the boxes shaded in gray) the unshaded
boxes at either side of the figure show specific intervention
strategies that relate to the node, and the volume of rele-
vant guidelines/guidance and evaluation evidence identified.
Some guidelines/guidance and evaluation studies were broad
in scope and, therefore, applicable to more than one node of
the pathway. In some areas, there were relatively more ex-
amples mapped than other areas, suggesting variability in the
extent to which the sexual healthcare pathway had been cov-
ered. For example, among sexually active teenagers (who had
not necessarily acquired infection) we mapped two clinical
guidelines and five published evaluation studies addressing
strategies for sexual health education and prevention of STIs.
The guidelines were a DH “toolkit” for health professionals
to promote good sexual health and prevent HIV (5), and
Scottish guidelines of the management of chlamydia infec-
tion (16) emphasizing, among other things, the importance
of primary prevention. Of the five studies, four were system-
atic reviews of the effectiveness of interventions to prevent
STIs (8;9;10;15). Two of these five were tertiary evidence
briefing reviews, which themselves included systematic re-
views of effectiveness of prevention. The fifth study was an
on-going evaluation of a school- and community-based ini-
tiative to promote safer sex and chlamydia testing. Areas of
the pathway where fewer examples of guidelines/guidance or
evidence were identified and mapped included management
of acute and long-term complications.
Prioritization
The gaps that were identified were translated into fifty-four
specific topic questions to be considered by a panel of stake-
holders in the Delphi exercise. Of the fifty-four, forty-two
were research questions, seven were topics suitable for po-
tential clinical guidelines/guidance, and five suitable for po-
tential technology appraisals, underpinning guidance to the
health service. The topics spanned the entire care pathway,
although many of the research questions related to the for-
mative nodes, notably primary prevention of STIs.
The stakeholders were asked to identify and score up to
a maximum of ten of the forty-two research questions, and a
maximum of six of twelve guideline/guidance suggestions.
Response rates for participation in the Delphi consensus pro-
cess were 10/19 (53 percent) and 13/19 (68 percent) for the
first and second rounds, respectively.
Outputs
Five guideline/guidance topics were prioritized, and these
have been discussed at prioritization committees for po-
tential commissioning. Of the forty-two research topics,
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Teenagers
Inappropriate
Appropriate
Effective
Ineffective
Teenage pregnancy
(outside scope of project)
Population screening*
Strategies for
improving
compliance
G = 1: E = 0
Effective methods
for secondary
prevention of STIs
e.g. health advisors
G = 6: E = 3
Screening
No STI
Opportunistic
screening
G = 4: E = 5
Strategies for sexual
health education in
teenagers
Strategies for dealing
with acute
complications
G = 6: E = 0
Strategies for dealing
with L/T
complications
G = 1: E = 0
KEY
G: Guideline / guidance
E: Evidence
*: Noguideline/guidance
or evidence
NB. Guidelines/guidance
and evidence can apply to
morethan one node of
the pathway
G = 1: E = 5
Accessibility,
acceptability, and
effectiveness of sexual
health services for
teenagers - GUM, GP,
and contraceptive
services G = 0: E = 2
Effective methods
of partner
notification/contact
tracing in
teenagers*
Strategies for
raising awareness in
secondary care*
Investigation of STIs
and risk factors for
STIs G = 7: E = 4
Strategies for improving access
to information*
Strategies for
reducing STI
transmission
G = 2: E = 5
Strategies for deferring on set of
sexual activity
Management of STIs
and risk factors for
STIs G = 9: E = 0
Strategies for risk
reduction G = 2: E = 8
Figure 2. Care pathway for the prevention and management of sexually transmitted infections (STIs) in teenagers. GP, general practitioner.
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twenty-three were within the scope of the HTA Program,
whereas nineteen were relevant to other DH research pro-
grams. Of the 23 HTA research topics, 14 came under the re-
mit of the Program’s Disease Prevention Panel and underwent
a further round of prioritization by the panel in March 2006.
After discussion by the panel, four of these were prioritized
and advertised as part of a call for proposals in December
2006 (two primary research, and two secondary research).
Case Study 2: Recognition, Assessment,
and Management of Acute Pain in Children
and Young People (Ages 28 Days to
19 Years)
Scope. As with case study 1, the topic of the second
case study was chosen for its broad nature and importance to
policy. Pain is an area of health care associated with variations
in clinical practice, high healthcare costs, and significant
morbidity for patients.
Inclusion/exclusion criteria were (i) Topic area: acute
pain defined as “pain associated with actual and potential
tissue damage, which is of recent onset and probable lim-
ited duration” to exclude predicted pain; (ii) Age range: age
28 days to 19 years; (iii) Interventions: recognition, assess-
ment, and management (pharmacological and nonpharma-
cological interventions); (iv) Country: Any. Due to resource
and time limitations, only policy literature was reviewed in
this case study.
Care pathway
In common with the STI pilot, a published care pathway
was not available from the literature. We developed a simpli-
fied generic pathway of care for a child experiencing acute
pain that was clinically validated. The pathway sets out the
various options for the management of acute pain in chil-
dren and young people by health and other professionals.
As with the STI pilot, the pathway was extensive, ranging
from the initial recognition of pain of varying severity (e.g.,
through visual analogue and rating scales) to formal assess-
ment, pharmacological management, and nonpharmacologi-
cal interventions (e.g., cooling for burns or temperature, dis-
traction therapy, splinting, psychological therapies) in either
primary or secondary care. Effective management is defined
as using these different interventions together/in the correct
sequence, where appropriate.
Literature Search
As well as the literature sources outlined above, several
topic-specific databases and Internet sites were searched, in-
cluding The British Pain Society, The Joint Royal Colleges
Ambulance Liaison Committee, and the London Emergency
Medicine Paediatric Interest Group.
Mapping and Synthesis: Results
A total of sixteen sets of clinical guidelines/guidance were
included: eight from the United Kingdom, four from the
United States, and one each from France, New Zealand,
Australia, and Canada. Not all of the documents included and
reviewed described themselves as clinical guidelines. For ex-
ample, one document was described as a “position statement”
on the management of acute pain, whereas another was an
evaluation report of a nursing project to reach consensus on
guidelines for the implementation of standardized pediatric
pain assessment in hospital settings. The documents varied in
length from very short summaries of key recommendations
with little supporting documentation to large reports with nu-
merous appendices. The overall methodological quality was
generally poor. There was little description of the background
and methods used, and few were developed according to es-
tablished guideline/guidance methodology. Many are now
out of date, being over 5 years old at the time of the project.
Figure 3 shows the care pathway and the results of the
mapping. Some nodes of the pathway appeared to be well
covered by the literature, such as assessment of pain in pre-
hospital and hospital settings, and pharmacological manage-
ment. Other areas were more neglected, such as training and
screening tools on recognition of pain.
In terms of “gaps” in the guidelines/guidance literature
two levels of need were identified. There was a general need
for up to date child-focused clinical guidelines/guidance cov-
ering all aspects of acute pain care, developed according to
rigorous and transparent methodology. Several more specific
needs were identified from the guidelines that were identified
including evidence-based recommendations for the recogni-
tion and assessment of pain (to include training), appropri-
ate pharmacological and nonpharmacological interventions,
the safety and effectiveness of both nonpharmacological and
pharmacological interventions, duration of benefit of pain
control measures and the frequency of re-assessment, and
the choice of treatment in relation to severity. These need to
be age-specific (infant, child, adolescent) and setting-specific
(primary care, paramedic care, and hospital emergency and
in-patient), with particular attention to the paramedic setting.
Prioritization and Outputs
After mapping, eight guideline/guidance topics were identi-
fied for the Delphi virtual workshop. These topics included
separate guidelines for pharmacological and nonpharmaco-
logical management of acute pain in, in hospital and prehos-
pital settings, training and screening tools for the recognition
of acute pain in children and young people, and validated
and effective acute pain assessment tools for use with chil-
dren and young people in the primary and secondary (to
include A&E) care and paramedic settings. The stakehold-
ers were asked to identify and score up a maximum of four
of the eight guideline/guidance suggestions. Three of these
were prioritized by the workshop and have been discussed at
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Figure 3. Care pathway for the recognition, assessment, and management of acute pain in children.
prioritization committees for potential commissioning. Re-
sponse rates for participation in the Delphi consensus process
were 7/14 (50 percent) and 11/14 (79 percent) for the first
and second rounds, respectively.
DISCUSSION
This study is one of the few published examples of the
evaluation of a mapping technique to set the policy and re-
search agenda in health (17;21). This pilot evaluation has
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provided valuable feedback on one particular method for
mapping research and policy priorities in health technology
assessment.
We believe that, by applying the principles of system-
atic review methodology, we increased the transparency of
the process, reduced the potential for bias, and generally
enhanced the credibility of the approach. This was par-
ticularly important for ensuring that the outcomes (policy
and research questions) were appropriate and that the pro-
cess is accountable. Application of these rigorous meth-
ods in this pilot required adequate staff capacity with in-
put from experienced researchers and a trained information
scientist.
The pilot was ultimately successful in that we identified
a large number of research and policy gaps and suggestions
for clinical guidelines. These findings have been fed subse-
quently into policy prioritization committees, and primary
and secondary research topics have been scoped, prioritized,
and advertised for commissioning.
A key finding from this study is that a framework re-
flecting current policy and practice in the particular specialty
is essential. Previous mapping exercises have used National
Service Frameworks (3;4) or a cancer specific “Common
Service Outline” (13), or decision trees (2) as an operational
framework. To our knowledge, this study is the first to use a
care pathway. This strategy had several advantages and pro-
vided an invaluable infrastructure. However, “off the shelf”
published pathways were not available and construction of
a bespoke pathway was not straightforward, despite help-
ful input from stakeholders. That said, for the purpose of
specialty mapping, it does not necessarily have to be a “gold
standard” care pathway covering every possible management
strategy in detail. The level of detail required ultimately de-
pends on the aims and scope of the map and the needs of end
users.
As with all methodologies, there are limitations. The pro-
cess was time consuming, and although it was systematic, it
was not always exhaustive. Adequate time is needed to de-
velop the care pathway, conduct literature searches, screen
literature for inclusion, appraise and synthesize the literature,
map to the care pathway, and translate gaps into clear and
specific research or guidance questions. The process of secur-
ing input from stakeholders, all of whom had busy schedules,
was also time consuming. Use of the “virtual” prioritization
process probably helped to ensure the wider involvement
of both clinical, nonclinical, and patients participants, and
in greater numbers. The time and energy required to solicit
involvement of stakeholders should not be underestimated.
Based on our experience in this pilot, we believe that
mapping may be particularly useful where there is a need for
a whole topic area to be prioritized, in addition to the rou-
tine identification and prioritization of available technologies
across a spectrum of conditions. In this sense, it can con-
tribute to “joined-up” policy making, ensuring consistency
and reducing the potential for duplication.
CONCLUSION
Specialty mapping has the potential to generate topics for
research and policy by identifying gaps in evaluation evi-
dence and clinical guidance. The implications for research
and policy are numerous. The identification of gaps in the
policy literature can inform effective policy decisions. De-
pending on the number of evidence gaps identified there is
the potential to commission high-quality research. Research
capacity building will need to be maintained if this approach
is to be used more widely to ensure demand is met.
In terms of the way forward, the methodology should
be refined in the light of the lessons learned from this pilot
exercise. It will be important to assess its value across a
variety of topic areas. It should continue to be as participative
and as inclusive as possible in the spirit of involving all in
setting the agenda for health technology assessment.
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